Opko Health, Inc. Completes Acquisition Of Inspiro Medical Ltd.
5/22/2014 9:44:24 AM
MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) announced that it has completed the acquisition of Inspiro Medical Ltd. (“Inspiro”), an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. Inspiro’s Inspiromatic™ is a “smart” easy-to-use dry powder inhaler with several advantages over existing devices.
Help employers find you! Check out all the jobs and post your resume.
comments powered by